Kolkata’s FMCG giant Emami just made its boldest bet yet on India’s health and wellness wave. Here’s everything about the ₹200 crore deal, what AloFrut is, what this means for the beverage market — and why Emami is calling this its “third engine of growth.”
The Deal — What Happened
Emami Limited has executed a definitive agreement on April 1, 2026, to acquire the remaining 73.5% stake in Axiom Ayurveda Private Limited for an aggregate consideration not exceeding ₹200 crore.
The Kolkata-headquartered FMCG major had previously held a 26.5% stake in Axiom Ayurveda (acquired in September 2023). With this deal, Emami’s ownership will rise to 100%, making Axiom Ayurveda a wholly-owned subsidiary of the group.
The board approved the transaction on March 31, 2026, with closure expected by June 30, 2026. The deal is a cash transaction and does not qualify as a related party transaction, as per regulatory disclosures.
Deal Structure — Three Tranches, Phased Acquisition
The acquisition is being executed in a phased manner:
| Phase | Stake Acquired | Cumulative Holding |
| Pre-deal (Sep 2023) | 26.5% | 26.5% |
| First Tranche (April 1, 2026) | 36.7% (84,30,909 shares) | 63.2% |
| Remaining Tranches (by Jun 30, 2026) | ~36.8% | 100% |
| Total Consideration | — | Up to ₹200 crore |
The remaining stake will be acquired over the next three months, subject to customary closing conditions and applicable regulatory requirements.
What is Axiom Ayurveda — The Company Behind AloFrut
Axiom Ayurveda traces its origins to 1995 and is headquartered in Ambala, Haryana. It operates across health and wellness categories, with brands including AloFrut, Jeevan Ras and Mukti Gold.
Its flagship brand, AloFrut, an aloe vera pulp-based fruit beverage, has established a strong presence across general trade and institutional channels. The product capitalises on the clear consumer shift away from carbonated sodas toward healthier, functional drink alternatives.
Beyond beverages, Axiom also has a presence in personal care, which contributes 15–20% to its branded business.
Key Brands Under Axiom Ayurveda:
| Brand | Category | Highlights |
| AloFrut | Aloe vera pulp fruit beverages | Flagship — strong general trade + institutional presence |
| Jeevan Ras | Herbal health juices | Ayurvedic wellness segment |
| Mukti Gold | Health beverages | Natural / functional drinks |
Revenue — From ₹107 Crore to ₹180 Crore
Axiom reported a turnover of around ₹107 crore in FY25. With Emami’s full ownership, distribution muscle and brand-building capabilities, the company is expected to scale up to approximately ₹180 crore in FY26.
Emami’s management views Axiom as a “profitable and growing company” — an important qualification in a market where many health beverage startups are still burning cash.
The revenue jump target from ₹107 crore to ₹180 crore in a single year represents a 68% growth — an aggressive but achievable target given Emami’s distribution reach across 6+ lakh retail outlets nationally.
New CEO — Harkirat Bedi Takes Charge
To drive this expansion, Emami has appointed Harkirat Bedi (formerly Vice President at Dabur Nepal) as the CEO of Axiom Ayurveda.
The appointment of a Dabur veteran signals that Emami is serious about scaling Axiom as a standalone beverage powerhouse rather than merely absorbing it into existing divisions. Bedi’s experience navigating competitive Ayurvedic consumer markets at Dabur makes him well-suited for this challenge.
Emami’s “Third Engine of Growth” — Strategic Significance
Emami’s management has explicitly called this acquisition its “third engine of growth” — a strategic framing that deserves unpacking.
Emami’s existing two engines are:
- Personal Care — BoroPlus, Navratna, Fair and Handsome, 7 Oils in One
- Healthcare — Zandu Balm, Zandu Pancharishta, Mentho Plus
The health beverage segment represents a genuinely new category for the group. Emami’s management stated: “With the completion of the acquisition, we bring Axiom fully into the Emami fold, marking our formal entry into the fast-growing and huge beverage segment. This aligns with our strategy of leveraging multiple growth levers, where strategic investments in new-age, synergistic segments complement our core businesses to drive future growth.”
Why This Deal Makes Sense — India’s Health Beverage Boom
This acquisition is not happening in isolation. It is part of a broader strategic wave across Indian FMCG.
The Ayurveda and natural products market is estimated at $10–12 billion in India, growing at 15–20% annually — significantly outpacing traditional FMCG categories. With several regional brands scaling from ₹100–500 crore, large FMCG firms are increasingly acquiring such companies to tap into this fast-growing health and wellness segment.
Who is Emami Competing With in Beverages?
| Competitor | Their Health Beverage Play |
| Dabur | Real Fruit juices, Hommade, Ayurvedic drinks |
| ITC | B Natural juices, Sunfeast |
| Tata Consumer | Tata Gluco+, NourishCo beverages |
| PepsiCo | Tropicana, Lipton |
| Coca-Cola | Maaza, Minute Maid |
Emami’s entry into beverages via Axiom gives the group a differentiated Ayurvedic positioning that is genuinely distinct from multinational beverage brands. Axiom’s target of ₹180 crore revenue for FY26 — up from ₹107 crore — depends on continued market demand and Emami’s successful integration of Axiom’s supply chain and distribution.
What the Founder Says
Rishabh Gupta, Founder, Axiom Ayurveda, commented: “Consumers today are increasingly moving away from carbonated beverages and seeking healthier alternatives without compromising on taste. At Axiom, we have always focused on delivering a differentiated offering that combines health and taste, which has been central to our journey and that makes us different from other beverage companies. I am confident that Emami is the right partner to take Axiom into its next phase of growth.”
Emami’s Market Context
Emami has a market capitalisation of approximately ₹17,146 crore. The company has seen its stock face headwinds in recent months, which makes this strategic expansion into a high-growth category a significant forward-looking move.
Analysts generally hold a ‘Buy’ rating on Emami with average price targets around ₹630–636.
The health beverage segment is growing at an estimated CAGR of 7.93%, demanding unique strategies and continuous innovation. Emami’s broad distribution network — built over decades of FMCG operations — could provide a significant competitive edge in scaling AloFrut beyond its current geographic footprint.
Key Deal Timeline
| Date | Milestone |
| September 2023 | Emami first acquires 26.5% stake in Axiom |
| March 31, 2026 | Emami board approves full acquisition |
| April 1, 2026 | Definitive agreement executed; first tranche (36.7%) acquired |
| By June 30, 2026 | Remaining ~36.8% to be acquired — Axiom becomes 100% subsidiary |
Emami-Axiom Ayurveda Deal 2026 — FAQs
Q. How much is Emami paying for Axiom Ayurveda?
Up to ₹200 crore for the remaining 73.5% stake, bringing total ownership to 100%.
Q. What does Axiom Ayurveda make?
AloFrut (aloe vera pulp-based fruit beverages), Jeevan Ras and Mukti Gold — all in the health and wellness beverages space, plus some personal care products.
Q. How much revenue does Axiom Ayurveda generate?
₹107 crore in FY25. Emami expects to grow this to ₹180 crore in FY26.
Q. Who is the new CEO of Axiom Ayurveda?
Harkirat Bedi, formerly Vice President at Dabur Nepal, has been appointed CEO.
Q. When will the Emami-Axiom deal close?
The full acquisition is expected to complete by June 30, 2026, in phased tranches.
Q. Why is Emami buying Axiom Ayurveda?
To formally enter India’s fast-growing health beverage segment, using Axiom as a “third engine of growth” alongside Emami’s personal care (BoroPlus, Navratna) and healthcare (Zandu) businesses.
Q. Is this an Emami-related party transaction?
No — UIDAI regulations confirm this is not a related party transaction. No Emami promoter or group company has any interest in Axiom beyond Emami’s own associate status.
